Align Technology (ALGN) Getting Somewhat Positive Press Coverage, Analysis Shows
News stories about Align Technology (NASDAQ:ALGN) have been trending somewhat positive this week, according to Accern Sentiment. Accern rates the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Align Technology earned a news impact score of 0.19 on Accern’s scale. Accern also gave media coverage about the medical equipment provider an impact score of 46.3253595022231 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:
- Align Technology, Inc. (ALGN) Receives Average Rating of “Buy” from Analysts (americanbankingnews.com)
- Align Technology (ALGN) Stock Rating Lowered by BidaskClub (americanbankingnews.com)
- Hot Stock under Consideration – Align Technology Inc (NASDAQ … – Alpha Beta Stock (alphabetastock.com)
- Align Technology (ALGN) Reports Advanced Treatment Planning Patent Affirmed by Three-Judge Panel (streetinsider.com)
- Cramer: Hunting for Bargains (finance.yahoo.com)
A number of brokerages recently commented on ALGN. Piper Jaffray Companies reissued a “buy” rating and issued a $300.00 price objective on shares of Align Technology in a research note on Wednesday, January 31st. Credit Suisse Group increased their price objective on shares of Align Technology from $276.00 to $290.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Stifel Nicolaus increased their price objective on shares of Align Technology from $245.00 to $265.00 and gave the company a “buy” rating in a research note on Tuesday, November 21st. BidaskClub cut shares of Align Technology from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, January 31st. Finally, Zacks Investment Research cut shares of Align Technology from a “buy” rating to a “hold” rating in a research note on Thursday, February 1st. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Align Technology presently has an average rating of “Buy” and an average price target of $258.54.
Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Tuesday, January 30th. The medical equipment provider reported $1.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.96 by $0.23. Align Technology had a net margin of 15.71% and a return on equity of 28.55%. The company had revenue of $421.30 million for the quarter, compared to analysts’ expectations of $395.88 million. During the same period last year, the company earned $0.59 EPS. The firm’s revenue for the quarter was up 43.7% compared to the same quarter last year. sell-side analysts anticipate that Align Technology will post 4.49 EPS for the current year.
In other Align Technology news, VP Emory Wright sold 5,025 shares of the firm’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $263.68, for a total transaction of $1,324,992.00. Following the sale, the vice president now directly owns 80,762 shares of the company’s stock, valued at approximately $21,295,324.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Joseph Lacob sold 29,724 shares of the firm’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $260.91, for a total transaction of $7,755,288.84. The disclosure for this sale can be found here. Insiders have sold a total of 82,029 shares of company stock worth $21,369,243 over the last ninety days. 1.60% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: This report was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://www.thecerbatgem.com/2018/02/13/align-technology-algn-getting-somewhat-positive-press-coverage-analysis-shows.html.
Align Technology Company Profile
Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.